Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q3 2020 · 10-Q
Revenue—
Net Income-$1.73M-$1.73MN/M vs Q3 2019 EPS Diluted-$0.39-$0.39N/M vs Q3 2019 Operating Income-$1,396,000N/M Operating Cash Flowderived-$2,299,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,313,000N/M ended Sep 30, 2020 · filed Oct 22, 2020 · 22 d after period end